Panelists discuss how patient portal use improves communication by allowing patients to report adverse effects with photos ...

Panelists discuss how patients newly diagnosed with multiple myeloma often face emotional and informational overload, but ...

A quality-adjusted time without symptoms or toxicity analysis identified better outcomes for patients with RCC treated with belzutifan vs everolimus.